Antifungal prophylaxis in solid-organ transplant recipients: Considerations for clinical trial design

Clinical Infectious Diseases

Volumn 39, Issue SUPPL. 4, 2004, Pages

  Singh, Nina ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CASPOFUNGIN; CYCLOSPORIN; ECHINOCANDIN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; RAPAMYCIN; SIMVASTATIN; TACROLIMUS; VORICONAZOLE;

ANTIFUNGAL PROPHYLAXIS; ARTICLE; ASPERGILLUS; CANDIDA; DRUG SAFETY; DRUG TOLERABILITY; FUNGAL COLONIZATION; HUMAN; INFECTION PREVENTION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; METHODOLOGY; MYCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CLINICAL TRIALS; FORECASTING; HUMANS; IMMUNOCOMPROMISED HOST; PREVENTIVE MEDICINE; RESEARCH DESIGN; RISK FACTORS; TRANSPLANTATION; TRANSPLANTS;

EID: 12844281077     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421957     Document Type: Article

References (37)

1. Kusne S, Torre-Cisneros J, Manez R, et al. Factors associated with invasive lung aspergillosis and significance of positive cultures after liver transplantation. J Infect Dis 1992; 166:1379-83.
2. Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine 1999; 78:123-38.
3. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16:677-88.
4. Alexander BD. Prophylaxis of invasive mycoses in solid organ transplantation. Curr Opin Infect Dis 2002; 15:583-9.
5. Singh N. Antifungal prophylaxis in organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis 2000; 31:545-53.
6. Kanj SS, Welty-Wolf K, Madden J, et al. Fungal infections in lung and heart-lung transplant recipients: report of 9 cases and review of the literature. Medicine 1996; 75:142-56.
7. Mehrad B, Paciocco G, Martinez FJ, et al. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001; 119:169-75.
8. Fortun JP, Martin-Davila P, Moreno S, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002; 8:1065-70.
9. Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36:46-52.
10. Yeldandi V, McCabe MA, Larson R, et al. Aspergillus and lung transplantation. J Heart Lung Transplant 1995; 14:883-90.
11. Singh N, Wagener MM, Marino IR, Gayowski T. Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation 2002; 73:63-7.
12. Husain S, Tollemar J, Dominguez EA, Baumgarten K, Humar A, Paterson DL, Wagener MM, Kusne S, Singh N. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003; 75:2023-9.
13. Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131:729-37.
14. Everett JE, Wahoff DC, Statz GKJ, et al. Characterization and impact of wound infection after pancreas transplantation. Arch Surg 1994; 129:1310-7.
15. Benedetti E, Gruessner A, Troppmann C, et al. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg 1996; 183:307-16.
16. Humar A, Kandaswamy R, Granger D, Russo MW, Grussner AD, Sutherland DER. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000; 231:269-75.
17. Kaufman DB, Leventhal JR, Stuart J, Abecassis MM, Fryer JP, Stuart FP. Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. Transplantation 1999; 67:586-93.
18. Rigotti P, Cadrobbi R, Baldan N, et al. Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience. Clin Nephrol 2000; 53:52-4.
19. Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 1997; 64:716-20.
20. Ascioglu S, Rex JH, Bennett JE, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
21. Venkataramanan R, Zang S, Gayowski T, Singh N. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother 2002; 46:3091-3.
22. Capone D, Gentile A, Imperatore P, Palmiero G, Basile V. Effects of itraconazole on tacrolimus blood concentrations in a renal transplant recipients. Ann Pharmacother 1999; 33:1124-5.
23. Billaud EM, Guillemain R, Tacco F, Chevalier P. Evidence for a pharmacokinetic interaction between itraconazole and tacrolimus in organ transplant patients. Br J Clin Pharmacol 1998; 46:271-4.
24. Malouf MA, Bicknell M, Glanville AR. Rhabdomyolysis after lung transplantation. Aust N Z J Med 1997; 27:186.
25. Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring replacement therapy. Transplantation 2001; 71:910-3.
26. Winston DJ, Busuttil RW. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 2002; 74:688-95.
27. Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. Transplantation 1995; 59:45-50.
28. Fortun J, Martin-Davila P, Moreno S, et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother 2003; 52:813-9.
29. Singh N, Gayowski T, Wagener MM. Intensive care unit management in liver transplant recipients: beneficial effect on survival and preservation of quality of life. Clin Transplant 1997; 11:113-20.
30. Singh N, Mieles L, Yu VL, Gayowski T. Invasive aspergillosis in liver transplant recipients: association with candidemia, consumption coagulopathy, and failure of prophylaxis with low-dose amphotericin B. Clin Infect Dis 1993; 17:906-8.
31. Lorf T, Braun F, Ruchel R, Muller A, Sattler B, Ringe B. Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation. Mycoses 1999; 42:47-53.
32. Varo E, Tome S, Bustamante M, et al. Fungal infection prophylaxis in high-risk liver transplant recipients [abstract J-138]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 1998.
33. Husain S, Alexander B, Munoz P, et al. Opportunistic mycelial fungi in organ transplant recipients; emerging importance of non-Aspergillus mycelial infections. Clin Infect Dis 2003; 37:221-9.
34. Kontoyiannis DP, Lewis RE, Osberov N, et al. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother 2003; 51:313-6.
35. Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003; 22:258-66.
36. Husain S, McCurry J, Dauber J, Kusne S, Singh N. Invasive aspergillosis in lung transplant recipients in the era of modern immunosuppression [abstract 344]. In: Proceedings of the 40th annual meeting of the Infectious Diseases Society of America (Chicago). Alexandria, VA: Infectious Diseases Society of America, 2002.
37. Westney GE, Kesten S, De Hoyos A, Chapparro C, Winton T, Maurer JR. Aspergillus infection in single and double lung transplant recipients. Transplantation 1996; 61:915-9.